As previously announced, on June 1, 2012, BioSante Pharmaceuticals, Inc. ("BioSante") effected a one-for-six reverse split of its issued and outstanding common stock and class C special stock.

BioSante is filing this current report on Form 8-K to present selected financial data for the fiscal years ended December 31, 2011, 2010, 2009, 2008 and 2007 and for the quarterly periods ended March 31, 2012 and 2011, as adjusted to reflect the June 1, 2012 one-for-six reverse stock split.

The information contained in Exhibit 99.1 to this report is incorporated by reference in this Item 8.01 and should be read in conjunction with, and as a supplement to, information contained in BioSante's annual report on Form 10-K for its fiscal year ended December 31, 2011, quarterly report on Form 10-Q for the quarterly period ended March 31, 2012 and any other reports or filings made by BioSante with the Securities and Exchange Commission.

(d) Exhibits.

Exhibit No.                               Description
   99.1       Selected Financial Data of BioSante for the fiscal years ended
              December 31, 2011, 2010, 2009, 2008 and 2007 and for the quarterly
              periods ended March 31, 2012 and 2011, as adjusted to reflect the
              one-for-six reverse split of BioSante's issued and outstanding
              common stock and class C special stock on June 1, 2012 (filed
              herewith)